A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2002
12/11/2002	CN1384884A Herpes virus vectors for dendritic cells
12/11/2002	CN1384878A IREN protein, its preparation and use
12/11/2002	CN1384876A Modular transport systems for molecular substances and production and use thereof
12/11/2002	CN1384840A Antibody of human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin
12/11/2002	CN1384835A Tricycle inhibitors of poly(ADP-ribose) polymerases
12/11/2002	CN1384834A Pyrrolo [2,3-d] pyrimidine nucleoside analoys
12/11/2002	CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384822A Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-3,3-diphenylpropionate and use thereof endothelin antagonist
12/11/2002	CN1384754A Method and composition for treating prostate cancer
12/11/2002	CN1384749A Use of diphophonic acid in treatment of vasculogenesis
12/11/2002	CN1384747A Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions
12/11/2002	CN1384744A Isoxazole derivatives to be used as phosphodiestesterase VII inhibitors
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384116A New-type alpha-interferon
12/11/2002	CN1383881A Gansukang capsule
12/11/2002	CN1383880A Tumor treating pill
12/11/2002	CN1383878A Chinese herbal medicine recipe for treating gastric cancer
12/11/2002	CN1383860A Medicine for treating bladder cancer
12/11/2002	CN1383856A Tumor treating medicine
12/11/2002	CN1383851A Lung cancer treating medicine and its prepn
12/11/2002	CN1095845C Method and device for production of lyophilized hydrochloride-1 beta, 10 beta-epoxy-13-dimethylamino-guaia-3(4)-en-6,12-olide
12/11/2002	CN1095844C Alcohol derivative of Triperygium wilfordii lactone, its prep. and application
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/11/2002	CN1095828C Antitumor 2-aminocarbonyl-1-2-bis (methylsulfonyl)-1-(substd.) hydrazines
12/11/2002	CN1095677C 化合物 Compound
12/11/2002	CN1095673C New application of medicine containing ginsenoside Rhl
12/11/2002	CN1095672C Traditional Chinese medicine for treating cirrhosis and liver cancer
12/11/2002	CN1095658C Foot bathing lotion for eliminating tumor
12/10/2002	US6493570 Administering a halogenated xanthene to a patient prior to imaging, a portion of said halogenated xanthene being retained in said diseased tissue; and imaging said patient using a detected signal from said halogenated xanthene
12/10/2002	US6492530 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
12/10/2002	US6492507 Polynucleotides encoding human eosinophil-derived basic protein
12/10/2002	US6492504 Nucleotide sequence of mammastatin and methods of use
12/10/2002	US6492497 Specific binding members for TGFbeta1
12/10/2002	US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems
12/10/2002	US6492425 Inhibitors of transcription factor-NF-κB
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
12/10/2002	US6492410 Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer
12/10/2002	US6492409 Such as 5-(1-(3-aminopropyl)-3-indolyl)-1-(3-indolyl)-1,3-dihydroimidazol-2-one; protein kinase c inhibitors; high solubility; reduced color; treating inflammatory and/or immunological disorders
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492383 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492376 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492353 1,3-dihydroxy-20,20-cycloalkyl-vitamin D3analogs
12/10/2002	US6492335 Glycoconjugates from modified camptothecin derivatives (20-O-linkage)
12/10/2002	US6492333 Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors
12/10/2002	US6492331 NL8 tie ligands homologues
12/10/2002	US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6491951 Soluble compositions of toremifene
12/10/2002	US6491914 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions including the anti-idiotypic monoclonal antibodies
12/10/2002	US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002	US6491187 Inverted aerosol dispenser
12/10/2002	CA2116773C Triazolylated tertiary amine compound or salt thereof
12/10/2002	CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament
12/10/2002	CA1341407C Minactivin
12/08/2002	CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002	CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/05/2002	WO2002097395A2 P-cadherin as a target for anti-cancer therapy
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097119A2 Use of the indication of the expression of splice variants of gene 21 for the diagnosis and treatment of tumour diseases
12/05/2002	WO2002097116A2 Delivery system for nucleic acids
12/05/2002	WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097059A2 Chromosome-based platforms
12/05/2002	WO2002097053A2 Small molecule antagonists of bcl2 family proteins
12/05/2002	WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	WO2002097042A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
12/05/2002	WO2002097035A2 Secreted proteins
12/05/2002	WO2002097033A2 Antibodies that immunospecifically bind to trail receptors
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096951A1 Molecules for disease detection and treatment
12/05/2002	WO2002096948A2 Engineered tetravalent antibodies and methods of use
12/05/2002	WO2002096943A1 Stat6-activating genes
12/05/2002	WO2002096933A1 2-{[n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives
12/05/2002	WO2002096932A1 Transporters and ion channels
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases
12/05/2002	WO2002096926A1 Modulators of pharmacological agents
12/05/2002	WO2002096921A1 Novel glucose derivative inducing apoptosis, process for producing the same, and use thereof as medicine
12/05/2002	WO2002096913A1 Substituted di(hydroxy/alkoxy)silicon phthalocyanines and their uses
12/05/2002	WO2002096911A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
12/05/2002	WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002	WO2002096909A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
12/05/2002	WO2002096903A2 Chemical derivatives and the use thereof as an anti-telomerase agent
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096892A1 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
12/05/2002	WO2002096889A1 Quinazolinone compound and method of preparation and use thereof in preparing anticancerous medicament
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096887A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002	WO2002096883A1 Tricyclic compounds useful as angiotensin ii agonists
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands

1 ... 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 ... 2211